Staar surgical announces expiration of “window shop” period; no competing acquisition proposals received

Lake forest, calif.--(business wire)--staar surgical company (nasdaq: staa), the global leader in phakic iols with the evo family of implantable collamer® lenses (evo icl™) for vision correction, today announced the expiration of the 45-day “window shop” period under the terms of the previously announced merger agreement with affiliates of alcon (six/nyse: alc). the “window shop” period expired at 11:59 p.m., eastern time, on september 19, 2025, and no competing acquisition proposal was receive.
ALC Ratings Summary
ALC Quant Ranking